Terns Pharmaceuticals, Inc. (NASDAQ: TERN)
$5.0300
-0.2150 ( -1.57% ) 359.4K
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
Market Data
Open
$5.0300
Previous close
$5.2450
Volume
359.4K
Market cap
$425.97M
Day range
$5.0010 - $5.2550
52 week range
$4.3200 - $11.4000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jan 06, 2025 |
| 4 | Insider transactions | 1 | Jan 06, 2025 |
| 4 | Insider transactions | 1 | Dec 16, 2024 |
| 4 | Insider transactions | 1 | Dec 09, 2024 |
| 8-k | 8K-related | 13 | Dec 03, 2024 |
| 4 | Insider transactions | 1 | Nov 19, 2024 |
| 3 | Insider transactions | 2 | Nov 19, 2024 |
| 8-k | 8K-related | 13 | Nov 18, 2024 |
| 8-k | 8K-related | 13 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 58 | Nov 12, 2024 |